Bionano Genomics Inc (NAS:BNGO)
$ 0.9 -0.004 (-0.44%) Market Cap: 62.20 Mil Enterprise Value: 47.58 Mil PE Ratio: 0 PB Ratio: 0.63 GF Score: 46/100

Bionano Genomics Inc To Acquire Purigen Biosystems Transcript

Nov 29, 2022 / 01:30PM GMT
Release Date Price: $19 (-6.86%)
Operator

Good day, and welcome to the Bionano Genomics conference call regarding its acquisition of Purigen Biosystems. Today's conference is being recorded. At this time, I would like to turn the call over to Amy Conrad from Investor Relations. Please go ahead.

Amy Conrad
Juniper Point - Founder & CEO

Thank you, Keith, and good morning, everyone. Welcome to the Bionano Genomics conference call, where we will be discussing the acquisition of Purigen Biosystems. Leading the call today is Dr. Erik Holmlin, CEO of Bionano. He is joined by Chris Stewart, CFO of Bionano; and Dr. Klint Rose, previously CFO and Co-Founder of Purigen, who are available for questions.

After market closed yesterday, Bionano issued a press release announcing Bionano and Purigen's entry into a merger agreement for the proposed acquisition of Purigen. A copy of the release can be found on the Investor Relations page of Bionano's website.

I would like to remind everyone that certain statements made during this conference call may be forward-looking, including statements about

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot